Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab - Wikidata - wikimedia - TriplyDB

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

http://www.wikidata.org/entity/Q26799069

about

Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.New onset or transition of disease state of psoriatic arthritis during treatment with ustekinumab: A single-center retrospective study.Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease.

P2860

Q26738918-9950A108-B386-4BE3-80CC-51889307F6D0 Q48102896-4BE86414-4329-4C63-A931-BA9207AA1582 Q48297584-BBF49FB9-0AA9-429D-BA23-CE25ACCB8E9C Q55315725-E6F3F983-A74B-4B7E-BBF0-CD4CEBEDB69D

P2860

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

http://www.wikidata.org/entity/Q26799069

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@ast

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@en

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@nl

type

label

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@ast

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@en

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@nl

prefLabel

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@ast

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@en

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@nl

P1433

Q26799069-A81F1BA8-E14A-41D2-942E-B950AFF1EB7F

P1476

Q26799069-DE0E8E08-FCD7-472A-88B7-5F2EA55F18D0

P2093

Q26799069-35EE059F-50DF-41C1-993E-85FD4DC225DF

Q26799069-9874A1A0-9641-4F43-BBDF-734D92DF0E3A

Q26799069-B460D703-C166-47C1-A78D-5E1A48572965

Q26799069-E2D920D7-11BF-4D80-949B-C2A887809234

P2860

Q26799069-53818EB0-5C91-4930-B0A6-5D3F676911EF

Q26799069-58224C98-6BD2-4154-A519-E1D6B6B8C4E5

Q26799069-7CFA4091-E027-4DBC-A48C-74C148AF1219

Q26799069-C63998D7-E74C-485F-99C9-8BED60C9262F

Q26799069-CD995BD4-CFF6-4910-A959-0E3C91824018

Q26799069-F2FDCB15-D913-4D0D-8D02-E0BE8DD9153E

P304

Q26799069-7D002365-CC9C-407F-95B9-04049517F3AE

P31

Q26799069-23614742-F3FA-4570-A776-1ACD83B640AB

P3181

Q26799069-B423B8F6-861A-4196-978F-900A1BF56ECE

P356

Q26799069-A423CF72-7CD9-4EE5-85FB-C6B99F37F8B1

P407

Q26799069-DE5A9940-0869-42D7-BC46-B01106821BD0

P433

Q26799069-584BCF4D-FE29-43B3-B145-08370F5CAFDF

P478

Q26799069-BAE69DE1-DE51-42EA-B0B0-BFF70AEFC02F

P577

Q26799069-1AA5AD89-B888-4ABC-89F7-167F16A9288C

P5875

Q26799069-20B96B56-890C-457B-86FF-EFDEB976E6D6

P698

Q26799069-085825F8-88BC-4659-9BCC-0D0F5EFDD782

P921

Q26799069-CEB346A4-7CFC-4440-B41C-21147A48CE13

P3181

P356

P1433

P1476

Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab

@en

P2093

Antoanela Čarija

http://www.w3.org/2001/XMLSchema#string

Daniela Marasović-Krstulović

http://www.w3.org/2001/XMLSchema#string

Ivo Ivić

http://www.w3.org/2001/XMLSchema#string

Neira Puizina-Ivić

http://www.w3.org/2001/XMLSchema#string

P2860

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action.

Ustekinumab in clinical practice: response depends on dose and previous treatment.

Ustekinumab associated with flares of psoriatic arthritis.

Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

P304

2114-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4529206

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/RHEUMATOLOGY/KEV263

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280872616

http://www.w3.org/2001/XMLSchema#string

P698

26242857

http://www.w3.org/2001/XMLSchema#string

P921